
AICUBE is an innovative startup based in Milan focused on proactive prevention and predictive medicine through AI-powered solutions. The company develops a non-invasive, AI-driven digital platform and device called DOC.D© that measures crucial health biomarkers such as salivary glucose and tremor severity in Parkinson's patients. Their technology integrates hardware, software, and consumables to provide real-time health data analysis, enabling personalized healthcare and better self-awareness. AICUBE collaborates with leading industrial and research partners to industrialize and scale their solutions, aiming to enhance secondary prevention and early diagnosis of diseases, thus improving health outcomes and reducing complications.

AICUBE is an innovative startup based in Milan focused on proactive prevention and predictive medicine through AI-powered solutions. The company develops a non-invasive, AI-driven digital platform and device called DOC.D© that measures crucial health biomarkers such as salivary glucose and tremor severity in Parkinson's patients. Their technology integrates hardware, software, and consumables to provide real-time health data analysis, enabling personalized healthcare and better self-awareness. AICUBE collaborates with leading industrial and research partners to industrialize and scale their solutions, aiming to enhance secondary prevention and early diagnosis of diseases, thus improving health outcomes and reducing complications.